Company Filed Second Patent Application to Extend Core Technology Applications MURRIETA, Calif. — Murrieta Genomics is pleased to announce that U.S. Patent and Trademark Office (USPTO) has issued a Notice of Allowance for its subsidiary simplSEQ’ s patent application No. 17/331,532 for certain claims related to the isolation and immobilization of nucleic acids and uses thereof. This novel approach to […]

Dublin, Ireland: ERS Genomics Limited (‘ERS’) is pleased to report that China Patent No. 2017105856905 has been granted. This new patent covers methods and compositions for use of CRISPR/Cas9 in eukaryotes. ERS, co-founded by Dr. Emmanuelle Charpentier, 2020 Nobel Prize winner for gene-editing, provides access to the foundational CRISPR/Cas9 intellectual property. With this patent in China, the fundamental […]

VENLO, the Netherlands — QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) and BD (Becton, Dickinson and Company) (NYSE: BDX) announced today that they have reached a settlement in the patent infringement lawsuit related to QIAGEN’s NeuMoDx™ 96 and NeuMoDx™ 288 clinical PCR systems that QIAGEN acquired from NeuMoDx Inc. in 2020. Under terms of […]

BICO, the world’s leading bio convergence company, has been granted two patents relating to the regulation and precise control of bioink’s processing temperatures in 3D Bioprinters. The first patent, US 11,046,001, was granted in the United States and relates to temperature regulation of the printbed to enable precise control of the gelation process of bioprinted structures with temperature-sensitive […]

Advancement Expected to Further Accelerate Development of mRNA Vaccines and Therapeutics SAN DIEGO — Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, announced today that the European Patent Office has issued a new patent, No. 3352584, to the company’s TriLink BioTechnologies subsidiary. The patent relates […]

Unique approach harnesses Evonetix’s thermally-controlled DNA-on-chip technology to simplify writing, accessing and reading stored DNA Demonstrates potential application of Evonetix’s technology beyond gene synthesis Cambridge, UK – EVONETIX LTD (‘Evonetix’), the synthetic biology company developing a desktop platform for scalable, high-fidelity and rapid gene synthesis, today announced it has been granted patent GB 2576304 for its […]

BIRMINGHAM, Ala. — TriAltus Bioscience announced that the U.S Patent and Trademark Office has issued U.S. Patent No 10,759,830 for its CLīM affinity tag system, which delivers proteins with ultra-high purity and yield in a single step. The patent, entitled “Bacterial colicin-immunity protein purification system,” covers mutations made to colicin E7, a naturally occurring e.coli protein, […]

UK Intellectual Patent Office (UK IPO) has granted RevoluGen’s third patent covering its spin-based Fire Monkey High Molecular Weight (HMW) DNA extraction/size selection technology RevoluGen now owns controlling IP covering novel chemistry, column matrix and elution method Fire Monkey HMW-DNA Extraction/Size Selection produces library-ready homogenous, long-length DNA (average appx. 100kb +) for short- and long-read […]

Agreement to Cross License Single Cell Technologies Ends all Ongoing Legal Disputes  PLEASANTON, Calif. — 10x Genomics, Inc. (Nasdaq: TXG) today announced that it has entered into a global settlement and cross-license agreement with Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb). The agreement resolves all outstanding litigation and other proceedings between the two companies across […]

SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN) today affirmed its commitment to re-acquire GRAIL, a healthcare company focused on multi-cancer early detection. “This acquisition is procompetitive, and we have offered far-reaching structural and behavioral remedies to address any potential concerns. Illumina will continue to work with the European Commission (EC) to ensure that it has […]